Where some see danger and upheaval, investors see opportunity. And the harrowing Zika virus is no different. Investors are jumping into stocks focused on detecting or wiping out the virus.
Inovio (INO) said on Monday that it initiated a clinical study of its preventive Zika vaccine in 160 subjects in Puerto Rico.
Trade-Ideas LLC identified Inovio Pharmaceuticals (INO) as a weak on high relative volume candidate